Further processing options
Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) Eligible For High Dose Melphalan (HDM)
Saved in:
Journal Title: | Blood |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , , , , , , , |
In: | Blood, 122, 2013, 21, p. 1873-1873 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Society of Hematology
|
Subjects: |